首页> 外文期刊>Infectious diseases in obstetrics and gynecology >Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women.
【24h】

Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women.

机译:阴道内克林霉素乳膏对孕妇妊娠结局和阴道微生物菌群异常的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To determine whether intravaginal clindamycin cream reduces the incidence of abnormal pregnancy outcome in women with abnormal vaginal microbial flora graded as intermediate or BV and to investigate the effect of the antibiotic on vaginal microbial flora. METHODS: A prospective cohort study of pregnant women in an antenatal clinic of a district general hospital. The subjects were 268 women who had abnormal vaginal microbial flora at first clinic visit by examination of a Gram-stained vaginal smear and 34 women with a normal vaginal flora. Two hundred and thirty-seven women were evaluable. Women with abnormal Gram-stained smears (graded as II or III) on clinic recall were randomised to receive treatment (intravaginal clindamycin cream) or placebo and followed to assess outcome of pregnancy, vaginal flora, and detection of Mycoplasma hominis and Ureaplasma urealyticum after treatment. RESULTS: Abnormal outcomes of pregnancy were not significantly different in treated and placebo groups by Chi square (P = 0.2). However, women with grade III flora responded better to clindamycin than women with grade II flora by numbers of abnormal outcomes (P = 0.03) and return to normal vaginal flora (P = 0.01) (logistic regression analysis model). This may be due to differences in vaginal bacterial species in these grades. Women whose abnormal vaginal flora had spontaneously returned to normal on follow-up and were therefore not treated (revertants) had as many abnormal outcomes as placebos suggesting that damage by abnormal bacterial species occurred early in pregnancy. CONCLUSIONS: Gram-stain screening distinguishing grade II from grade III flora may be helpful in prescribing treatment other than clindamycin for women with grade II flora. Earlier diagnosis and treatment may be more effective in preventing an abnormal outcome, possibly as soon as pregnancy is diagnosed or even offered as a pre-conception screen.
机译:目的:确定阴道内克林霉素乳膏是否可降低阴道微生物菌群等级为中级或BV的女性异常妊娠结局的发生率,并研究抗生素对阴道微生物菌群的影响。方法:在地区综合医院产前诊所对孕妇进行前瞻性队列研究。受试者为268位在首次门诊就诊时通过革兰氏染色阴道涂片检查具有异常阴道菌群的女性,以及34位具有正常阴道菌群的女性。有237名妇女是可评估的。将临床召回时革兰氏染色涂片异常(等级为II或III)的妇女随机接受治疗(阴道内克林霉素乳膏)或安慰剂,然后评估妊娠结局,阴道菌群以及治疗后对人型支原体和解脲支原体的检测。结果:按卡方检验,治疗组和安慰剂组的妊娠异常结局无显着差异(P = 0.2)。然而,具有III级菌群的女性对克林霉素的反应优于具有II级菌群的女性,其结果异常数量多(P = 0.03),而阴道菌群恢复正常(P = 0.01)(逻辑回归分析模型)。这可能是由于这些级别的阴道细菌种类不同。异常阴道菌群在随访中自发恢复正常并因此未接受治疗的妇女(复归型)与安慰剂一样多的异常预后,表明异常细菌种类造成的损害在妊娠早期发生。结论:革兰氏染色筛查可将II级和III级菌群区分开来,对于克林霉素治疗II级菌群的女性可能有助于开出治疗方案。早期诊断和治疗可能更有效地预防异常结局,可能是在诊断为妊娠或什至是将其作为孕前筛查手段时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号